Back to Insider Trading View Full Company Profile

AXSM

HEALTHY

Axsome Therapeutics, Inc.

CIK: 0001579428

Strong Sell (90% confidence)

Last activity: 2 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Revenue $50.04M
Net Income -$18.33M
Total Cash $315.35M
Total Debt $180.71M
Debt/Equity 10.81
Current Ratio 67.65

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
TABUTEAU HERRIOT
Chief Executive Officer
0 7 -$41.55M
7,229 shares
$1.34M
Saad Mark E
OTHER
0 2 -$6.21M
10,002 shares
$1.65M
Pizzie Nick
Chief Financial Officer
0 1 -$2.26M
42,588 shares
$8.00M
Maizel Ari
Chief Commercial Officer
0 1 -$1.38M
Holdings: -
Value: -

Recent Transactions

SELL TABUTEAU HERRIOT (Chief Executive Officer)

32,410 shares @ $185.60

$6.02M

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Pizzie Nick (Chief Financial Officer)

12,000 shares @ $187.92

$2.26M

Jan 22, 2026

Conviction: | View SEC Filing →
SELL Maizel Ari (Chief Commercial Officer)

7,500 shares @ $184.44

$1.38M

Jan 21, 2026

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

31,261 shares @ $170.38

$5.33M

Jan 7, 2026

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

29,450 shares @ $172.33

$5.08M

Jan 6, 2026

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

78,703 shares @ $171.28

$13.48M

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Saad Mark E (OTHER)

31,346 shares @ $165.18

$5.18M

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Saad Mark E (OTHER)

6,231 shares @ $165.18

$1.03M

Dec 31, 2025

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

10,558 shares @ $148.18

$1.56M

Dec 4, 2025

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

20,163 shares @ $146.94

$2.96M

Dec 3, 2025

Conviction: | View SEC Filing →
SELL TABUTEAU HERRIOT (Chief Executive Officer)

49,252 shares @ $144.59

$7.12M

Dec 2, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.